In addition, a Portuguese FH study found only 48% of its total received cases with clinical diagnosis of FH had genetic defects on LDLR, APOB or PCSK9, leaving the other 52% of FH cases with possible undiscovered gene mutations [10]. This evidence concerns the gene APOB and familial hyperaldosteronism.